ZappRx and Bayer announced an agreement to provide a more efficient approach to accessing specialty medications and associated support programs.
ZappRx is a digital health company that streamlines the complex processes associated with prescribing specialty medications. The company will support patients living with pulmonary hypertension and those with relapsing-remitting multiple sclerosis, conditions within Bayer’s Specialty Medicines portfolio. Subsequent to the integration with